Official conference page for 2026 Rare Hematology Conference, Atlanta . https://binaytara.org/projects/conferences/2026-rare-hematology-conference-atlanta
Saturday, November 14th, 2026
All timings are in Eastern Time (EDT, GMT-04:00) time.
Session Chair: Nisha Joseph, MD
08:25 AM - 08:35 AM
Amyloidosis: Optimal Therapy and the Role of Transplant
08:35 AM - 08:45 AM
Looking to the Future: Can We Cure Multiple Myeloma?
08:45 AM - 09:05 AM
Case-Based Discussions 1: When Monoclonal Gammopathy Becomes Significant
09:05 AM - 09:25 AM
Case-Based Discussion 2 - POEMs
09:40 AM - 09:50 AM
Topic 1 - Updates in Gene Therapy
09:50 AM - 10:00 AM
Topic 2 - Updates in current management of sickle cell disease
10:00 AM - 10:20 AM
Case-Base Discussion 1
10:20 AM - 10:40 AM
Case-Based Discussion 2
10:40 AM - 10:50 AM
Topic 1 - Chronic Myelomonocytic Leukemia: Are Hypomethylating Agents the Standard of Care?
10:50 AM - 11:00 AM
Systemic Mastocytosis - The Role of KIT Inhibition – Michael Hochman, MD
11:00 AM - 11:20 AM
Case-Based Discussion: Evaluation and Management of Hypereosinophilic Syndromes
11:20 AM - 11:40 AM
Case-Based Discussion 2 - VEXAS Syndrome: Diagnosis and Management
12:40 PM - 12:50 PM
Peripheral T-cell lymphomas – Rahul Nayak, MD
12:50 PM - 01:00 PM
Contemporary Classification and Therapeutic Strategies in Castleman Disease – Locke Bryan, MD
01:00 PM - 01:20 PM
Case-Based Discussion 1 - CTCL
01:20 PM - 01:40 PM
Case-Based Discussion 2 - LGL
01:40 PM - 01:50 PM
Topic 1 - Hemophilia
01:50 PM - 02:00 PM
Thrombotic microangiopathy
02:00 PM - 02:20 PM
Case-Based Discussion 1
02:20 PM - 02:40 PM
Case-Based Discussion 2
03:00 PM - 03:10 PM
Topic 1 -Systemic Mastocytosis - The Role of KIT Inhibition in Systemic Mastocytosis
03:10 PM - 03:20 PM
Therapeutic Strategies in Histiocytic Disorders.... or HLH?
03:20 PM - 03:40 PM
Case-Based Discussion 1 - BPDCN
03:40 PM - 04:00 PM
Case-Based Discussion 2
